ClinicalTrials.gov
public full text
Public Domain
The Novel 18F-labeled MAO-B PET Tracer Study in Parkinsonism Patients
This study mainly aims to prospectively evaluate the changes of reactive astrogliosis in Parkinsonism patients of Chinese population by the novel 18F-labeled MAO-B PET tracer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Consistency of Serial CSF alpha-Synuclein Seed Amplification Assay Results in the Parkinson's Progression Marker Initiative#150420
- Vergleich einer Parkinson-Kohorte mit einer Nicht-Parkinson-Kohorte hinsichtlich psychosozialer und körperlicher Auswirkungen der COVID-19-Pandemie / Lisa-Marie Chidex ; Gutachter: Thomas Bahmer ; Betreuer: Walter Mätzler#664605
- Consistency of Serial CSF alpha-Synuclein Seed Amplification Assay Results in the Parkinson’s Progression Marker Initiative#442460
- Consistency of Serial CSF alpha-Synuclein Seed Amplification Assay Results in the Parkinson’s Progression Marker Initiative#152060
- REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study#808100
Record · ID 1008288
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive